| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |